Literature DB >> 29783171

GHEP-ISFG collaborative exercise on mixture profiles (GHEP-MIX06). Reporting conclusions: Results and evaluation.

P A Barrio1, M Crespillo2, J A Luque3, M Aler4, C Baeza-Richer5, L Baldassarri6, E Carnevali7, P Coufalova8, I Flores9, O García10, M A García11, R González12, A Hernández13, V Inglés14, G M Luque15, A Mosquera-Miguel16, S Pedrosa17, M L Pontes18, M J Porto19, Y Posada20, M I Ramella21, T Ribeiro22, E Riego23, A Sala24, V G Saragoni25, A Serrano26, S Vannelli27.   

Abstract

One of the main goals of the Spanish and Portuguese-Speaking Group of the International Society for Forensic Genetics (GHEP-ISFG) is to promote and contribute to the development and dissemination of scientific knowledge in the field of forensic genetics. Due to this fact, GHEP-ISFG holds different working commissions that are set up to develop activities in scientific aspects of general interest. One of them, the Mixture Commission of GHEP-ISFG, has organized annually, since 2009, a collaborative exercise on analysis and interpretation of autosomal short tandem repeat (STR) mixture profiles. Until now, six exercises have been organized. At the present edition (GHEP-MIX06), with 25 participant laboratories, the exercise main aim was to assess mixture profiles results by issuing a report, from the proposal of a complex mock case. One of the conclusions obtained from this exercise is the increasing tendency of participating laboratories to validate DNA mixture profiles analysis following international recommendations. However, the results have shown some differences among them regarding the edition and also the interpretation of mixture profiles. Besides, although the last revision of ISO/IEC 17025:2017 gives indications of how results should be reported, not all laboratories strictly follow their recommendations. Regarding the statistical aspect, all those laboratories that have performed statistical evaluation of the data have employed the likelihood ratio (LR) as a parameter to evaluate the statistical compatibility. However, LR values obtained show a wide range of variation. This fact could not be attributed to the software employed, since the vast majority of laboratories that performed LR calculation employed the same software (LRmixStudio). Thus, the final allelic composition of the edited mixture profile and the parameters employed in the software could explain this data dispersion. This highlights the need, for each laboratory, to define through internal validations its criteria for editing and interpreting mixtures, and to continuous train in software handling.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Collaborative exercise; DNA analysis; Forensic genetics reporting; Mixture interpretation; Spanish and Portuguese-Speaking Working Group; Statistical evaluation

Mesh:

Year:  2018        PMID: 29783171     DOI: 10.1016/j.fsigen.2018.05.005

Source DB:  PubMed          Journal:  Forensic Sci Int Genet        ISSN: 1872-4973            Impact factor:   4.882


  4 in total

1.  Towards developing forensically relevant single-cell pipelines by incorporating direct-to-PCR extraction: compatibility, signal quality, and allele detection.

Authors:  Nidhi Sheth; Harish Swaminathan; Amanda J Gonzalez; Ken R Duffy; Catherine M Grgicak
Journal:  Int J Legal Med       Date:  2021-01-23       Impact factor: 2.686

Review 2.  Interpol review of forensic biology and forensic DNA typing 2016-2019.

Authors:  John M Butler; Sheila Willis
Journal:  Forensic Sci Int       Date:  2020-02-20       Impact factor: 2.395

Review 3.  A Review of Probabilistic Genotyping Systems: EuroForMix, DNAStatistX and STRmix™.

Authors:  Peter Gill; Corina Benschop; John Buckleton; Øyvind Bleka; Duncan Taylor
Journal:  Genes (Basel)       Date:  2021-09-30       Impact factor: 4.096

4.  Internal Validation of MaSTR™ Probabilistic Genotyping Software for the Interpretation of 2-5 Person Mixed DNA Profiles.

Authors:  Michael S Adamowicz; Taylor N Rambo; Jennifer L Clarke
Journal:  Genes (Basel)       Date:  2022-08-11       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.